Related Experiment Video
Updated: Sep 21, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Gender differences among persons entering medication treatment for opioid use disorder in the community
Angela Di Paola1, Noor Taweh1,2, Breanne E Biondi3
1Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA.
Background And Objectives:
We evaluated gender differences among persons initiating medications for opioid use disorder (MOUD).
Methods:
Analyses of baseline assessments for a study evaluating the impact of MOUD on outcomes included: demographics, DSM-5 diagnoses, depression severity, quality of life (QoL), and medication history (Nā=ā125).
Results:
When compared to men, women had a greater prevalence of generalized anxiety and posttraumatic stress disorders; and worse psychological QoL. Women were less likely to be prescribed psychiatric medications.
Discussion And Conclusions:
Women may benefit from tailored multidisciplinary programs with MOUD.
Scientific Significance:
This study identified that women with OUD seeking MOUD in the community had greater sedative hypnotic nonprescribed medication use and psychiatric comorbidity than men, all of which can contribute to poorer retention on MOUD and higher risk of morbidity and mortality. Thus, concurrent psychiatric disorder screening and treatment integrated with MOUD may improve retention on MOUD, opioid relapse and overdose for women.
Related Concept Videos
Panic Disorder
Drug Abuse and Addiction: Pharmacological Phenomena
Analgesia and Pain Management
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Therapy
Antianxiety Medications

